散发性和C9orf72相关ALS的神经递质定义退变模式
一项258人神经影像研究评估神经退变与神经递质受体分布的空间关联,比较散发性与C9orf72重复扩增携带者的ALS患者,发现散发性ALS主要累及GABA能、5-羟色胺能及κ阿片受体网络,而C9orf72相关ALS还涉及谷氨酸能、内源性大麻素及微胶质系统。
要点
- 散发性ALS退变与GABA-A α5、5-HT1a及κ阿片受体表达图空间关联。
- C9orf72相关ALS额外累及谷氨酸能、内源性大麻素及微胶质系统。
- 纵向分析提示与去甲肾上腺素转运体及GABAa5空间关联增加,但高脱落率限制推断。
核心结论
- 散发性ALS优先累及GABA能、5-羟色胺能及κ阿片介导网络。
- C9orf72相关ALS中谷氨酸能、内源性大麻素回路及微胶质介导神经炎症亦受累。
研究设计与样本
- 大型神经影像研究纳入258名参与者,按基因型分为散发性与C9orf72六核苷酸重复扩增携带者。
- 评估萎缩模式与神经递质受体拓扑分布之间的解剖关联,并在连续4个时间点进行横断面与纵向分析。
主要发现
- 散发性ALS神经退变与GABA-A受体α5选择性成分、5-羟色胺1a受体及κ阿片受体表达图存在拓扑关联。
- C9orf72 GGGGCC重复扩增患者神经元丢失除上述网络外,还偏向谷氨酸能、内源性大麻素及微胶质系统。
- 多时间点纵向分析显示局灶体积丢失与神经递质表达的时间关联动态变化,与去甲肾上腺素转运体和GABAa5空间关联增加,但高脱落率妨碍确定性纵向推断。
临床怎么用
- 神经递质受体关联图谱可为ALS靶向治疗开发策略提供依据。
局限性
- 纵向分析高脱落率妨碍确定性纵向推断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Amyotrophic lateral sclerosis (ALS) has a markedly distinctive clinical and neuroradiological signature, with the preferential involvement of specific brain networks and the apparent sparing of others. The molecular underpinnings of the strikingly selective anatomical vulnerability have not been fully elucidated to date despite the potential therapeutic relevance of characterizing neurotransmitter receptor-defined susceptibility to degeneration. METHODS: A large neuroimaging study was undertaken with 258 participants to systematically evaluate topological associations between neurodegeneration and neurotransmitter expression distributions. Patients were stratified based on their genetic profile into sporadic and C90rf72 hexanucleotide repeat expansion carriers. Anatomical associations were evaluated between patterns of atrophy and topological neurotransmitter receptor distributions. Cross-sectional and longitudinal trends were comprehensively evaluated over 4 consecutive timepoints. RESULTS: Our analyses reveal topological associations between neurodegeneration in sporadic ALS and GABA-A receptor α5-selective component (GABAa5), serotonin 1a receptor, and kappa opioid receptor expression maps. In addition to these networks, neuronal loss in patients with GGGGCC hexanucleotide repeat expansions exhibit predilection to glutamatergic, endocannabinoid, and microglial systems. Our multi-timepoint longitudinal analyses reveal dynamic temporal associations between focal volume loss and neurotransmitter expression with increasing spatial associations with noradrenaline transporter and GABAa5, but high attrition rates preclude definite longitudinal inferences. INTERPRETATION: Our data suggest the preferential vulnerability of GABAergic, serotonergic, kappa opioid mediated networks in sporadic ALS. In C9orf72-assocaited ALS, glutamatergic, endocannabinoid circuits are also susceptible and microglia-mediated neuroinflammation is also implicated. The comprehensive evaluation of neurotransmitter-receptor associations not only offer academic insights regarding pathophysiological processes in ALS, but may inform targeted therapy development strategies. ANN NEUROL 2026;100:948-961.
引用
- Tahedl M, Siah WF, Lope J, et al. Neurotransmitter-Defined Degeneration Patterns in Sporadic and C9orf72-Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic, Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems-Implications for Therapy Development. Ann Neurol. 2026. PMID: 42479906. doi:10.1002/ana.78316
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。